The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_004360.5(CDH1):c.832+1G>A

CA396459027

463795 (ClinVar)

Gene: CDH1
Condition: CDH1-related diffuse gastric and lobular breast cancer
Inheritance Mode: Autosomal dominant inheritance
UUID: cc34c30c-3789-40a7-9f1b-131a3a3bfb85

HGVS expressions

NM_004360.5:c.832+1G>A
NM_004360.5(CDH1):c.832+1G>A
NC_000016.10:g.68810342G>A
CM000678.2:g.68810342G>A
NC_000016.9:g.68844245G>A
CM000678.1:g.68844245G>A
NC_000016.8:g.67401746G>A
NG_008021.1:g.78051G>A
ENST00000261769.10:c.832+1G>A
ENST00000261769.9:c.832+1G>A
ENST00000422392.6:c.832+1G>A
ENST00000561751.1:c.455-1342G>A
ENST00000562836.5:n.903+1G>A
ENST00000566510.5:c.676+1G>A
ENST00000566612.5:c.832+1G>A
ENST00000611625.4:c.832+1G>A
ENST00000612417.4:c.832+1G>A
ENST00000621016.4:c.832+1G>A
NM_004360.3:c.832+1G>A
NM_001317184.1:c.832+1G>A
NM_001317185.1:c.-784+1G>A
NM_001317186.1:c.-988+1G>A
NM_004360.4:c.832+1G>A
NM_001317184.2:c.832+1G>A
NM_001317185.2:c.-784+1G>A
NM_001317186.2:c.-988+1G>A

Pathogenic

Met criteria codes 5
PS3 PVS1_Strong PS4_Moderate PM2_Supporting PM5_Supporting
Not Met criteria codes 6
BA1 BP2 BP5 BS2 BS3 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen CDH1 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 3.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
CDH1 VCEP
The CDH1 c.832+1G>A variant is a canonical splice variant in intron 6 predicted to result in a truncated or absent protein (PVS1_Strong, PM5_Supporting). The variant is absent from the gnomAD cohort (PM2_Supporting; http://gnomad.broadinstitute.org). This variant has been observed in three families meeting IGCLC criteria for HDGC (PS4_Moderate, internal clinical lab data). This variant has also been reported in the literature in families with LBC who do not meet criteria for HDGC (PMID: 36436516, 32489267, 34643667). RNA analysis demonstrated two out-of-frame transcripts, r.754_832del79 p.(V252Efs*4) and r.688_832del145 p.(L230Efs*4) (PS3; internal clinical lab data). In summary, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP criteria applied as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): PVS1_Strong, PS3, PS4_Moderate, PM2_Supporting, PM5_Supporting.
Met criteria codes
PS3
RNA analysis demonstrated two abnormal out-of-frame transcripts, r.754_832del79 p.(V252Efs*4) and r.688_832del145 p.(L230Efs*4) (Ambry).
PVS1_Strong
This variant is at a canonical splice site, and therefore PVS1_Strong is applied.
PS4_Moderate
This variant was identified in three families meeting IGCLC criteria for HDGC (Invitae, Ambry, NCI). The variant was also observed in four families with DGC, LBC and/or SRC tumours who do not meet criteria for HDGC (Ambry, NCI; PMID: 36436516, 32489267, 34643667) and in two families without DGC, LBC and/or SRC tumours.
PM2_Supporting
This variant is absent from populations in gnomAD, ExAC, 1000 Genomes and ESP.
PM5_Supporting
Apply PM5_Supporting to the variant with the alteration at canonical splicing site.
Not Met criteria codes
BA1
This variant is absent from populations in gnomAD, ExAC, 1000 Genomes and ESP.
BP2
To our knowledge, this variant has not been reported in cis or trans with a pathogenic variant.
BP5
To our knowledge, this variant has not been reported in a case with an alternate molecular basis for disease.
BS2
This variant was identified in three families meeting IGCLC criteria for HDGC (Invitae, Ambry, NCI). The variant was also observed in four families with DGC, LBC and/or SRC tumours who do not meet criteria for HDGC (Ambry, NCI) and in two families without DGC, LBC and/or SRC tumours.
BS3
RNA analysis demonstrated two abnormal out-of-frame transcripts, r.754_832del79 p.(V252Efs*4) and r.688_832del145 p.(L230Efs*4) (Ambry).
BS1
This variant is absent from populations in gnomAD, ExAC, 1000 Genomes and ESP.
Approved on: 2024-03-25
Published on: 2024-03-27
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.